---
title: "Pharscin Pharma: The company has become the holder of the marketing authorization for the Jian'er Xiaoshi oral liquid medication"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/256094289.md"
description: "Pharscin Pharma announced that the company has become the marketing authorization holder for Jian'er Xiaoshi Oral Liquid. This medication is a pediatric traditional Chinese medicine suitable for various symptoms in children caused by irregular eating habits. This change will enrich the company's product line, expand the retail market, increase the sales varieties in the pediatric digestive field, and promote the company's sustainable development"
datetime: "2025-09-05T09:14:30.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/256094289.md)
  - [en](https://longbridge.com/en/news/256094289.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/256094289.md)
generator: "portal-rs"
---

# Pharscin Pharma: The company has become the holder of the marketing authorization for the Jian'er Xiaoshi oral liquid medication

Pharscin Pharma announced that it recently received the approval notice for the supplementary application of the Jian'er Xiaoshi Oral Liquid from the National Medical Products Administration. The product has completed the change of the drug marketing authorization holder, and the company has become its drug marketing authorization holder. This drug is a pediatric traditional Chinese medicine that has the effects of strengthening the spleen and benefiting the stomach, regulating qi and aiding digestion. It is suitable for children suffering from symptoms such as poor appetite, abdominal distension, heat in the palms and soles, spontaneous sweating, fatigue, irregular bowel movements, and even anorexia and aversion to food caused by dietary irregularities damaging the spleen and stomach. This change will help enrich the company's product pipeline and expand the retail market, increasing the sales varieties in the pediatric digestive field and promoting the company's sustainable development

### Related Stocks

- [002907.CN](https://longbridge.com/en/quote/002907.CN.md)

## Related News & Research

- [Ganfeng Lithium, Lithium Argentina sign deal to jointly develop Consolidated Project via Millennial JV](https://longbridge.com/en/news/296790149.md)
- [Cocoa Prices Fall on Rising Nigerian Cocoa Exports](https://longbridge.com/en/news/296637826.md)
- [Lithium Argentina, Ganfeng form PPG lithium brine joint venture in Argentina’s Salta province](https://longbridge.com/en/news/296777044.md)
- [Cheng Shin Rubber: 2026H1 net income surged 43.8% year-over-year, driven by higher revenue and improved margins](https://longbridge.com/en/news/296745040.md)
- [12:43 ETTarkett introduces new terrazzo-inspired Johnsonite® rubber tile collection](https://longbridge.com/en/news/296813198.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**